Adverum Biotechnologies Inc ADVM:NASDAQ

Last Price$1.40NASDAQ Previous Close - Last Trade as of 4:00PM ET 8/16/22
NASDAQ 15-minute delayed Bid/Ask Quotes
Today's Change0(0.00%)
Bid (Size)$1.40 (2)
Ask (Size)$1.44 (5)
Day Low / HighN/A - N/A
Volume55.00
 

View Pharmaceuticals: Major IndustryPeer Comparison as of 08/16/2022

 

Adverum Biotechnologies Inc ( NASDAQ )

Price: $1.40
Change: -0.01 (0.71%)
Volume: 55.00
4:00PM ET 8/16/2022
 
 

Atossa Therapeutics Inc ( NASDAQ )

Price: $1.09
Change: -0.05 (4.39%)
Volume: 2.3 K
4:00PM ET 8/16/2022
 
 

Infinity Pharmaceuticals Inc ( NASDAQ )

Price: $1.53
Change: +0.26 (20.47%)
Volume: 4.1 K
4:00PM ET 8/16/2022
 
 

NextCure Inc ( NASDAQ )

Price: $5.12
Change: -0.07 (1.35%)
Volume: 122.9 K
4:00PM ET 8/16/2022
 
 

Sesen Bio Inc ( NASDAQ )

Price: $0.72
Change: -0.01 (1.69%)
Volume: 3.9 K
4:00PM ET 8/16/2022
 

Read more news Recent News

--Chardan Research Trims Adverum Biotechnologies' Price Target to $2.50 From $3, Maintains Neutral Rating
10:27AM ET 8/12/2022 MT Newswires

(MT Newswires covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may...

-- Earnings Flash (ADVM) ADVERUM BIOTECHNOLOGIES Posts Q2 Loss $-0.44
4:09PM ET 8/11/2022 MT Newswires

...

--Truist Securities Upgrades Adverum Biotechnologies to Buy From Hold, Adjusts Price Target to $4 From $3
6:50AM ET 7/07/2022 MT Newswires

(MT Newswires covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may...

Adverum Biotechnologies Preparing to Begin Phase 2 Trial of ADVM-022 to Treat Eye Disease
4:32PM ET 7/06/2022 MT Newswires

Adverum Biotechnologies (ADVM) said Wednesday it has completed its Investigational New Drug amendment with the Food and Drug Administration and is...

View all Commentary and Analysis

The Carnage Under The Surface Of The Stock Market
1:51AM ET 1/25/2022 Seeking Alpha

The State Of Biotech In 2022
4:04AM ET 1/03/2022 Seeking Alpha

Company Profile

Business DescriptionAdverum Biotechnologies, Inc. is a clinical-stage gene therapy company that engages in the development of gene therapies for ocular and rare diseases. The company was founded by Mark S. Blumenkranz, Thomas W. Chalberg, Jr., Mitchell H. Finer, and Steven Daniel Schwartz on July 17, 2006 and is headquartered in Redwood City, CA. View company web site for more details
Address100 Cardinal Way
Redwood City, California 94063
Phone+1.650.656.9323
Number of Employees82
Recent SEC Filing08/11/2022S-8
President, Chief Executive Officer & DirectorLaurent Fischer
Chief Operating & Legal OfficerPeter Soparkar
Chief Financial Officer & Senior Vice PresidentJohn W. Rakow
Senior VP & Head-Technical OperationsHeikki Jouttijärvi

Company Highlights

Price Open$1.39
Previous Close$1.40
52 Week Range$0.80 - 2.57
Market Capitalization$138.3 M
Shares Outstanding98.8 M
SectorHealth Technology
IndustryPharmaceuticals: Major
Next Earnings Announcement11/03/2022

Options Summary

Call Open Interest (1d)*
Put Open Interest (1d)*
Call Volume (1d)*
Put Volume (1d)*
Put Call Open Interest Ratio (1d)*
Put Call Volume Ratio (1d)*
* Data delayed by up to 15 minutes

View all fundamentalsFundamentals

Price / EarningsN/A
Earnings per Share-$1.55
Beta vs. S&P 500N/A
Revenue$1.6 M
Net Profit MarginN/A
Return on Equity-51.94%

Analyst Ratings as of 07/06/2022

Buy
2
Overweight
0
Hold
2
Underweight
0
Sell
0
Consensus RecommendationConsensus Icon
Powered by Factset